PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
VRSK vs. DXCM
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between VRSK and DXCM is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

VRSK vs. DXCM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Verisk Analytics, Inc. (VRSK) and DexCom, Inc. (DXCM). The values are adjusted to include any dividend payments, if applicable.

1,000.00%2,000.00%3,000.00%4,000.00%5,000.00%6,000.00%JulyAugustSeptemberOctoberNovemberDecember
957.02%
3,962.94%
VRSK
DXCM

Key characteristics

Sharpe Ratio

VRSK:

1.04

DXCM:

-0.57

Sortino Ratio

VRSK:

1.47

DXCM:

-0.41

Omega Ratio

VRSK:

1.22

DXCM:

0.92

Calmar Ratio

VRSK:

1.50

DXCM:

-0.52

Martin Ratio

VRSK:

3.84

DXCM:

-0.97

Ulcer Index

VRSK:

5.02%

DXCM:

32.43%

Daily Std Dev

VRSK:

18.63%

DXCM:

54.91%

Max Drawdown

VRSK:

-30.88%

DXCM:

-94.61%

Current Drawdown

VRSK:

-5.94%

DXCM:

-50.84%

Fundamentals

Market Cap

VRSK:

$39.57B

DXCM:

$30.39B

EPS

VRSK:

$6.47

DXCM:

$1.65

PE Ratio

VRSK:

43.31

DXCM:

47.15

PEG Ratio

VRSK:

1.83

DXCM:

1.19

Total Revenue (TTM)

VRSK:

$2.82B

DXCM:

$3.95B

Gross Profit (TTM)

VRSK:

$1.77B

DXCM:

$2.44B

EBITDA (TTM)

VRSK:

$1.53B

DXCM:

$975.30M

Returns By Period

In the year-to-date period, VRSK achieves a 16.60% return, which is significantly higher than DXCM's -35.50% return. Over the past 10 years, VRSK has underperformed DXCM with an annualized return of 16.10%, while DXCM has yielded a comparatively higher 19.53% annualized return.


VRSK

YTD

16.60%

1M

-3.59%

6M

2.71%

1Y

17.91%

5Y*

13.86%

10Y*

16.10%

DXCM

YTD

-35.50%

1M

6.38%

6M

-31.38%

1Y

-34.82%

5Y*

8.46%

10Y*

19.53%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

VRSK vs. DXCM - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Verisk Analytics, Inc. (VRSK) and DexCom, Inc. (DXCM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for VRSK, currently valued at 1.04, compared to the broader market-4.00-2.000.002.001.04-0.57
The chart of Sortino ratio for VRSK, currently valued at 1.47, compared to the broader market-4.00-2.000.002.004.001.47-0.41
The chart of Omega ratio for VRSK, currently valued at 1.22, compared to the broader market0.501.001.502.001.220.92
The chart of Calmar ratio for VRSK, currently valued at 1.50, compared to the broader market0.002.004.006.001.50-0.52
The chart of Martin ratio for VRSK, currently valued at 3.84, compared to the broader market-5.000.005.0010.0015.0020.0025.003.84-0.97
VRSK
DXCM

The current VRSK Sharpe Ratio is 1.04, which is higher than the DXCM Sharpe Ratio of -0.57. The chart below compares the historical Sharpe Ratios of VRSK and DXCM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00JulyAugustSeptemberOctoberNovemberDecember
1.04
-0.57
VRSK
DXCM

Dividends

VRSK vs. DXCM - Dividend Comparison

VRSK's dividend yield for the trailing twelve months is around 0.56%, while DXCM has not paid dividends to shareholders.


TTM20232022202120202019
VRSK
Verisk Analytics, Inc.
0.56%0.57%0.70%0.51%0.52%0.67%
DXCM
DexCom, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

VRSK vs. DXCM - Drawdown Comparison

The maximum VRSK drawdown since its inception was -30.88%, smaller than the maximum DXCM drawdown of -94.61%. Use the drawdown chart below to compare losses from any high point for VRSK and DXCM. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-5.94%
-50.84%
VRSK
DXCM

Volatility

VRSK vs. DXCM - Volatility Comparison

The current volatility for Verisk Analytics, Inc. (VRSK) is 3.68%, while DexCom, Inc. (DXCM) has a volatility of 11.34%. This indicates that VRSK experiences smaller price fluctuations and is considered to be less risky than DXCM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%JulyAugustSeptemberOctoberNovemberDecember
3.68%
11.34%
VRSK
DXCM

Financials

VRSK vs. DXCM - Financials Comparison

This section allows you to compare key financial metrics between Verisk Analytics, Inc. and DexCom, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab